7
9.
Layek, M.; Reddy M. A., Rao, A. V. D.; Alvala, M.; Arunasree,
M. K.; Islam, A.; Mukkanti, K.; Iqbal, J.; Pal, M. Org. Biomol.
Chem. 2011, 9, 1004.
Fig. 4. 2D followed by 3D interaction diagram between interface residues
of MtbCM (where red color indicates A chain and orange is B chain) (PDB
code: 2FP2) and 4h that were prepared in Maestro visualizer (Schrödinger,
LLC).
10. (a) Taylor, R.D.; Jewsbury, P.J.; Essex, J.W. J. Comput. Aided
Mol. Des. 2002, 16, 151; (b) Ciemny, M.; Kurcinski, M.; Kamel,
K.; Kolinski, A.; Alam, N.; Schueler-Furman, O.; Kmiecik, S.
(2018-05-04). "Protein–peptide docking: opportunities and
challenges". Drug Disc. Today. 2018, 23, 1530.
In summary, the first β-CD mediated synthesis of 4-oxo-4,5,6,7-
tetrahydroindoles in water has been achieved via a 3-component
reaction of phenacyl bromide (1), primary amine (2) and
dimedone (3). A range of compounds was prepared by using this
environmentally friendly method in good yield (82-92%). The
catalyst β-CD could be recovered and recycled. Being neutral and
free from the use of any metal / hazardous catalyst the
methodology appeared to have advantages over to the previously
reported methods for the synthesis of this class of compounds.
The in silico docking studies predicted chorismate mutase (CM)
inhibitory properties of some of the tetrahydroindoles
synthesized that was supported by the results of in vitro assay.
Indeed, the compound 4h appeared to be best among them. Thus,
our effort facilitated identification of a new class of potential
inhibitors of CM and further studies are in progress towards this
direction. Overall, the current work involving green chemistry
approaches, small organic molecules and their in silico as well as
pharmacological studies would be of further interest.
11. (a) Prakash, P.; Aruna, B.; Sardesai, A. A.; Hasnain, S. E. J. Biol.
Chem. 2005, 280, 19641; (b) Agrawal, H.; Kumar, A.; Bal, N. C.;
Siddiqi, M. I.; Arora, A. Bioorg. Med. Chem. Lett. 2007, 17, 3053.
12. (a) Dagher, C.; Hanna, R.; Terentiev, P. B.; Boundel, Y. G.; Kost,
A. N.; Maskimov, B. I. J. Hetrocyclic Chem. 1982, 19, 645; (b)
Lambat, T. L.; Abdala, A. A.; Mahmood, S.; Ledade, P. V.;
Chaudhary, R. G.; Banerjee, S. RSC Advances, 2019, 9, 39735; (c)
Lee, I.; Kwon, M.; Lee, C. Bull. Korean Chem. Soc., 2012,33,1;
(d) Tanyeli, C.; Akhmedov, I.; Yazıcıoˇglu, E. Tetrahedron Lett.,
2004, 45, 9627
13. (a) Jiang, B.; Li, Y.; Tu, M. S.; Wang, S. L.; Tu, S. J.; Li, G. J.
Org. Chem. 2012, 77, 7497; (b) Maity, S.; Pathak, S.; Pramanik,
A. Eur. J. Org. Chem. 2013, 2013, 2479.
14. (a) Strecker, A. Justus Liebigs Annalen der Chemie. 1850, 75, 27–
Angew. Chem. Int. Ed. 2000, 39, 3168; (c) Zhu, J.; Bienaymé, H.
Eds., Multicomponent Reactions. Wiley-VCH: Weinheim, 2005,
468 Pages, ISBN: 3-527-30806-7; (d) For recent examples, see:
April 17, 2020.
15. Dinnea, N. K. R.; Mekalaa, R.; Reddya, S. P.; Sivaa, G. Y. S.;
Bannoath, C. K. Synth. Commun. 2018, 48, 1649.
Acknowledgements
https://doi.org/10.1080/00397911.2018.1458240
The authors thank the management of Dr. Reddy’s Lab
Ltd, Hyderabad, India, for continuous support and
encouragement. Authors also thank Prof P. Misra and his group
of DRILS, Hyderabad for in vitro assay.
16. Dhanunjaya Rao, A. V.; Vykunteswararao, B. P.; Bhaskarkumar,
T.; Jogdand, N. R.; Kalita, D.; Jaydeep, K. D.; Lilakar, J. K. D.;
Siddaiah, V.; Sanasi, P. D.; Raghunadh, A. Tetrahedron Lett.
2015, 56, 4714.
17. Kumar, A.; Tripathi, V. D.; Kumar, P. Green Chem. 2011, 13, 51.
18. Murthy, S. N.; Madhav, B.; Kumar, A. V.; Rao, K. R.; Nageswar,
Y. V. D. Helv. Chim. Acta 2009, 92, 2118.
Supplementary data
19. Reddy, G. R.; Reddy, T. R.; Chary, R. G.; Joseph, S. C.;
Mukherjee, S.; Pal, M. Tetrahedron Lett. 2013, 54, 6744.
20. (a) Konkala, K.; Chowrasia, R.; Manjari, P. S.; Domingues, N. L.
C.; Katla, R. RSC Adv., 2016, 6, 43339; (b) Patil, D. R.; Wagh, Y.
B.; Ingole, P. G.; Singh, K.; Dalal, D. S. New J. Chem., 2013,37,
3261.
21. (a) Karnes, J. J.; Benjamin, I. J. Phys. Chem. C 2017, 121, 19209;
(b) Shivhare, K. N.; Siddiqui, I. R. Supramol. Chem. 2019, 31, 52-
61.
22. (a) De, P.E.; Cereda, C.M.; Fraceto, L.F.; de Araújo, D.R.; Franz-
Montan, M.; Tofoli, G. R.; Ranali, J.; Volpato,M. C.; Groppo, F.
C. Expert Opin. Drug Deliv. 2012, 9, 1505; (b) Bai, C. C.; Tian,
B. R.; Zhao, T.; Huang, Q.; Wang, Z. Z. Molecules 2017, 22,
1475; doi:10.3390/molecules22091475
23. (a) Szejtli. J. Chem. Rev., 1998, 98, 1743; (b) Rekharsky, M. V.;
Inoue, Y. Chem. Rev., 1998, 98, 1875.
24. Ji, H.B.; Shi, D.P.; Shao, M.; Li, Z.; Wang, L.F. Tetrahedron Lett.
2005, 46, 2517.
25. Kim, S. K.; Reddy, S. K.; Nelson, B. C.; Vasquez, G. B.; Davis,
A.; Howard, A. J.; Patterson, S.; Gilliland, G. L.; Ladner, J. E.;
Reddy, P. T.; J. Bacteriol., 2006, 188, 8638.
26. Sasso, S.; Ramakrishnan, C.; Gamper, M.; Hilvert, D.; Kast, P.
FEBS J., 2005, 272, 375.
Supplementary data associated with this article can be found,
in the on line version, at xxxxxxxxx
References and notes
1.
2.
Haslam, E. Shikimic Acid: Metabolism and Metabolites; Wiley:
New York, 1993.
For a review, see: Khanapur, M.; Alvala, M.; Prabhakar, M.;
Kumar, K. S.; Edwin, R. K.; Saranya, P. S. V.K.S.; Patel, R. K.;
Bulusu, G.; Misra, P.; Pal, M. Bioorg. Med. Chem. 2017, 25,
1725.
3.
End to killer TB? Scientists identify an enzyme that may hold
4.
5.
Niu, S.; Zhou, T. -T.; Xie, C. -L.; Zhang, G. -Y.; Yang, X. -W.
Mar. Drugs 2017, 15, 230; doi:10.3390/md15070230
Andreev, I. A.; Manvar, D.; Barreca, M. L.; Belov, D. S.; Basu,
A.; Sweeney, N. L.; Ratmanova, N. K.; Lukyanenko, E. R.;
Manfroni, G.; Cecchetti, V.; Frick, D. N.; Altieri, A.; Kaushik-
Basu, N.; Kurkin, A. V. European J. Med. Chem. 2015, 96, 250.
Vojacek, S.; Schulig, L.; Wössner, N.; Geist, N.; Langel, W.;
Jung, M.; Schade, D.; Link, A. ChemMedChem 2019, 14, 853.
Baral, N.; Mishra, D. R.; Mishra, N. P.; Mohapatra, S.; Raiguru,
B. P.; Panda, P.; Nayak, S.; Nayak, M.; Kumar, P. S. J.
Heterocycl. Chem. 2020, 57, 575.
6.
7.
8.
Reddy, G. R.; Reddy, T. R.; Joseph, S. C.; Reddy, K. S.; Reddy,
L. S.; Kumar, P. M.; Krishna, G. R.; Reddy, C. M.; Rambabu, D.;
Kapavarapu, R.; Lakshmi, C.; Meda, T.; Priya, K. K.; Parsa, K. V.
L.; Pal, M. Chem. Commun., 2011, 47, 7779.
.
relationships that could have appeared to influence
the work reported in this paper.
Declaration of interests
☐The authors declare the following financial
interests/personal relationships which may be
considered as potential competing interests:
☒ The authors declare that they have no known
competing financial interests or personal